Literature DB >> 12505584

Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve.

Marcel Peltier1, Faouzi Trojette, Maurice Enriquez Sarano, Francesco Grigioni, Michel A Slama, Christophe M Tribouilloy.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12505584     DOI： 10.1016/s0002-9149(02)03010-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  22 in total

Review 1.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 2.  Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?

Authors:  D E Newby; S J Cowell; N A Boon
Journal:  Heart       Date:  2006-06       Impact factor: 5.994

3.  Calcific aortic stenosis: a disease ready for prime time.

Authors:  Nalini M Rajamannan
Journal:  Circulation       Date:  2006-11-07       Impact factor: 29.690

4.  Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis.

Authors:  Gloria Alvarez-Llamas; Tatiana Martín-Rojas; Fernando de la Cuesta; Enrique Calvo; Felix Gil-Dones; Veronica M Dardé; Luis F Lopez-Almodovar; Luis R Padial; Juan-Antonio Lopez; Fernando Vivanco; Maria G Barderas
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

5.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

6.  The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality.

Authors:  Reza Ardehali; Nicholas J Leeper; Andrew M Wilson; Paul A Heidenreich
Journal:  J Heart Valve Dis       Date:  2012-05

7.  Calcific aortic stenosis: medical and surgical management in the elderly.

Authors:  Nalini M Rajamannan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-12

Review 8.  The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

9.  Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography.

Authors:  Jean-Pierre Laissy; David Messika-Zeitoun; Jean-Michel Serfaty; Vincent Sebban; Elisabeth Schouman-Claeys; Bernard Iung; Alec Vahanian
Journal:  Heart       Date:  2007-05-04       Impact factor: 5.994

Review 10.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.